SE9002278L - Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel - Google Patents

Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel

Info

Publication number
SE9002278L
SE9002278L SE9002278A SE9002278A SE9002278L SE 9002278 L SE9002278 L SE 9002278L SE 9002278 A SE9002278 A SE 9002278A SE 9002278 A SE9002278 A SE 9002278A SE 9002278 L SE9002278 L SE 9002278L
Authority
SE
Sweden
Prior art keywords
medicine
preparation
application
inositol trisphosphate
effective
Prior art date
Application number
SE9002278A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE9002278D0 (sv
Inventor
M Siren
Original Assignee
Perstorp Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp Ab filed Critical Perstorp Ab
Priority to SE9002278A priority Critical patent/SE9002278L/
Publication of SE9002278D0 publication Critical patent/SE9002278D0/xx
Priority to DK91912558T priority patent/DK0536269T3/da
Priority to EP93101712A priority patent/EP0554861A1/de
Priority to PCT/SE1991/000439 priority patent/WO1992000079A1/en
Priority to AT91912558T priority patent/ATE165514T1/de
Priority to AU81886/91A priority patent/AU8188691A/en
Priority to EP91912558A priority patent/EP0536269B1/de
Priority to ES91912558T priority patent/ES2115616T3/es
Priority to US07/966,035 priority patent/US5284839A/en
Priority to DE69129331T priority patent/DE69129331T2/de
Priority to JP3156823A priority patent/JPH0639383B2/ja
Publication of SE9002278L publication Critical patent/SE9002278L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9002278A 1990-06-28 1990-06-28 Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel SE9002278L (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9002278A SE9002278L (sv) 1990-06-28 1990-06-28 Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel
DE69129331T DE69129331T2 (de) 1990-06-28 1991-06-19 Verwendung von inosittriphosphat zur zubereitung von medikamenten
AT91912558T ATE165514T1 (de) 1990-06-28 1991-06-19 Verwendung von inosittriphosphat zur zubereitung von medikamenten
EP93101712A EP0554861A1 (de) 1990-06-28 1991-06-19 Verwendung von Inositoltriphosphat zur Behandlung von Nierenerkrankungen
PCT/SE1991/000439 WO1992000079A1 (en) 1990-06-28 1991-06-19 The use of inositoltrisphosphate for the preparing of medicaments
DK91912558T DK0536269T3 (da) 1990-06-28 1991-06-19 Anvendelse af inositol-triphosphat til fremstilling af medikamenter
AU81886/91A AU8188691A (en) 1990-06-28 1991-06-19 The use of inositoltrisphosphate for the preparing of medicaments
EP91912558A EP0536269B1 (de) 1990-06-28 1991-06-19 Verwendung von inosittriphosphat zur zubereitung von medikamenten
ES91912558T ES2115616T3 (es) 1990-06-28 1991-06-19 Utilizacion de inositoltrisfosfato en la preparacion de medicamentos.
US07/966,035 US5284839A (en) 1990-06-28 1991-06-19 Use of inositoltrisphosphate to treat abnornal gastrointestinal motility and secretion
JP3156823A JPH0639383B2 (ja) 1990-06-28 1991-06-27 医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002278A SE9002278L (sv) 1990-06-28 1990-06-28 Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel

Publications (2)

Publication Number Publication Date
SE9002278D0 SE9002278D0 (sv) 1990-06-28
SE9002278L true SE9002278L (sv) 1991-12-29

Family

ID=20379887

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9002278A SE9002278L (sv) 1990-06-28 1990-06-28 Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel

Country Status (10)

Country Link
US (1) US5284839A (de)
EP (2) EP0554861A1 (de)
JP (1) JPH0639383B2 (de)
AT (1) ATE165514T1 (de)
AU (1) AU8188691A (de)
DE (1) DE69129331T2 (de)
DK (1) DK0536269T3 (de)
ES (1) ES2115616T3 (de)
SE (1) SE9002278L (de)
WO (1) WO1992000079A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9213215D0 (en) * 1992-06-20 1992-08-05 Wellcome Found Peptides
IT1265647B1 (it) * 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
US5827837A (en) * 1993-08-20 1998-10-27 The Regents Of The University Of California Polyanion anti-inflammatory agents
US5516653A (en) 1993-12-28 1996-05-14 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
US5545549A (en) 1994-02-03 1996-08-13 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
US5602024A (en) 1994-12-02 1997-02-11 Synaptic Pharmaceutical Corporation DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof
US5989920A (en) 1994-12-02 1999-11-23 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
FR2754709B1 (fr) 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
US6713265B1 (en) 1997-06-04 2004-03-30 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
CN1135983C (zh) * 2001-06-28 2004-01-28 中山大学 二酸（5－雄甾烯－17－酮－3β－羟基）二酯用于制备药物
GB0121709D0 (en) * 2001-09-07 2001-10-31 Imp College Innovations Ltd Food inhibition agent
KR100989647B1 (ko) 2001-09-24 2010-10-26 오레곤 헬스 앤드 사이언스 유니버시티 식습관의 변화
EP1585956A4 (de) * 2001-09-24 2009-10-21 Univ Oregon Health & Science Beurteilung von neuronen im nucleus arcuatus zum screening auf das essverhalten verändernde stoffe
US8058233B2 (en) * 2002-01-10 2011-11-15 Oregon Health And Science University Modification of feeding behavior using PYY and GLP-1
WO2003057235A2 (en) 2002-01-10 2003-07-17 Imperial College Innovations Ltd Modification of feeding behavior
KR20040051455A (ko) * 2002-12-12 2004-06-18 아미코젠주식회사 산화적 손상을 예방하기 위한 카이로이노시톨 또는피니톨의 용도 및 이들을 함유하는 당뇨합병증 예방용조성물
GB0300571D0 (en) * 2003-01-10 2003-02-12 Imp College Innovations Ltd Modification of feeding behaviour
GB0511986D0 (en) * 2005-06-13 2005-07-20 Imp College Innovations Ltd Novel compounds and their effects on feeding behaviour
TWI428346B (zh) * 2006-12-13 2014-03-01 Imp Innovations Ltd 新穎化合物及其等對進食行為影響
RU2563127C2 (ru) * 2009-07-07 2015-09-20 Нормоксис, Инк, Способ уменьшения мультилекарственной резистентности с использованием трипирофосфата инозита

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE465305B (sv) * 1986-04-16 1991-08-26 Perstorp Ab Anvaendning av inositolfosfat foer framstaellning av ett laekemedel
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
SE464059C (sv) * 1988-09-15 1997-06-02 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel

Also Published As

Publication number Publication date
DK0536269T3 (da) 1998-10-07
EP0536269A1 (de) 1993-04-14
US5284839A (en) 1994-02-08
DE69129331T2 (de) 1998-09-24
WO1992000079A1 (en) 1992-01-09
JPH0639383B2 (ja) 1994-05-25
ATE165514T1 (de) 1998-05-15
ES2115616T3 (es) 1998-07-01
AU8188691A (en) 1992-01-23
JPH04230220A (ja) 1992-08-19
EP0536269B1 (de) 1998-04-29
DE69129331D1 (de) 1998-06-04
EP0554861A1 (de) 1993-08-11
SE9002278D0 (sv) 1990-06-28

Similar Documents

Publication Publication Date Title
SE9002278L (sv) Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel
IT1241996B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
CA2093806A1 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
PT97638A (pt) Processo para a preparacao de compostos peptidicos e de composicoes farmaceuticas que os contem
ITRM910696A0 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
IL107157A0 (en) Immunopotentiatory agents and pharmaceutical compositions comprising them
ATE121295T1 (de) Augentropfenarzneimittel.
DK0416950T3 (da) Medikamenter
ATE181505T1 (de) Phosphozucker enthaltende pharmazeutische zubereitung
RU93053905A (ru) Оксипуриновые нуклеозиды и родственные им соединения, а также их ацильные производные для улучшения гемопоэза, фармацевтическая композиция и способ лечения и/или профилактики
ES2063432T3 (es) Compuestos farmaceuticos orales de dosis unitaria.
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
DE69209916D1 (de) Oral anzuwendende Arzneimittel Dapiprazol enthaltend
DE69808287D1 (de) Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid
DE69902925D1 (de) Ramoplaninhaltige neue injizierbare arzneizubereitungen
IT1243702B (it) Composti ad attivita' nootropa, procedimento per la loro preparazione e relative composizioni farmaceutiche
DE69310889D1 (de) Hochdosierte Vitamine A-Zusammensetzungen
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
IT9019002A1 (it) Composti otticamente attivi per la profilassi dell'insufficienza coronarica acuta e cronica, loro preparazione e composizioni farmaceutiche che li contengono
ITMI912238A1 (it) Composti ad attivita' mucolitica e antisettica, procedimento per la loro preparazione e relative composizioni farmaceutiche
ITMI911335A0 (it) Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911298A0 (it) Composti ad attivita' anticolinesterasi. procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT8919283A0 (it) Composizione farmaceutica comprendente come ingrediente attivo 3 n piperidinometil azino metilrifamicina s.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9002278-1